Biocartis Group NV, a molecular diagnostics company, has appointed Mike Kreitzinger as the Senior Vice President of Global Business Development, effective August 18, 2025. With over 25 years of experience in clinical diagnostics, Kreitzinger will focus on forming partnerships and alliances to drive commercial growth and integrate Biocartis solutions into the precision oncology ecosystem. Previously, he held senior roles at Illumina, Cepheid, and Alere.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.